This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Stacey Bremer
Advertisement
Stacey Bremer is Director, Product Stewardship Medical at Celanese.
Articles by Stacey Bremer
Advertisement
Latest Updated Articles
Mitigating the Risk from Excipient VariabilityPublished: August 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
5
